Literature DB >> 2139441

Sulfhydryl drug-induced eruption: a clinical and histological study.

K Kitamura1, M Aihara, J Osawa, S Naito, Z Ikezawa.   

Abstract

Sulfhydryl drug-induced skin eruptions were studied clinically and histologically in 23 patients. In this study, tiopronin, D-penicillamine, captopril and gold sodium thiomalate were considered to be sulfhydryl drugs, because they have a thiol group or release sulfhydryl compounds. The clinical features included skin eruptions that were maculopapular, erythema multiforme-like, eczematous, psoriasis-like, seborrheic dermatitis-like, Gibert-like, lichen planus-like, and pemphigus-like. These clinical findings were reminiscent of the wide variety of eruptions seen in cutaneous graft-versus-host reactions (GVHR). Histologically, areas of vacuolation and eosinophilic necrosis with a satellite infiltrate of lymphoid cells were seen in the epidermis, and perivascular infiltrates were noted in the dermis. These findings were similar to the histological picture of cutaneous GVHR. In skin tests with sulfhydryl compounds, 19 out of 20 subjects showed positive reactions, and autoantibodies were found in 8 out of 12 subjects tested. Sulfhydryl drugs seem likely to induce immunologic changes in the host and to produce a distinctive reaction similar to that of cutaneous GVHR.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139441     DOI: 10.1111/j.1346-8138.1990.tb01608.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  9 in total

1.  Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

Authors:  Allie Y Chen; Pei W Thomas; Alesha C Stewart; Alexander Bergstrom; Zishuo Cheng; Callie Miller; Christopher R Bethel; Steven H Marshall; Cy V Credille; Christopher L Riley; Richard C Page; Robert A Bonomo; Michael W Crowder; David L Tierney; Walter Fast; Seth M Cohen
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

2.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

3.  Thiol-derivatized minihepcidins retain biological activity.

Authors:  Eileen Fung; Kristine Chua; Tomas Ganz; Elizabeta Nemeth; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-01-06       Impact factor: 2.823

4.  Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.

Authors:  Shui Liu; Jian Zhang; Yonglin Zhou; Naiyu Hu; Jiyun Li; Yang Wang; Xiaodi Niu; Xuming Deng; Jianfeng Wang
Journal:  Br J Pharmacol       Date:  2019-12-09       Impact factor: 8.739

5.  Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors:  A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal:  Int J Biomed Sci       Date:  2013-09

6.  Embelin Restores Carbapenem Efficacy against NDM-1-Positive Pathogens.

Authors:  Nian-Zhi Ning; Xiong Liu; Fanghong Chen; Peng Zhou; Lihong Hu; Jian Huang; Zhan Li; Jie Huang; Tao Li; Hui Wang
Journal:  Front Microbiol       Date:  2018-01-25       Impact factor: 5.640

7.  Antihypertensive Effects of Polyphenolic Extract from Korean Red Pine (Pinus densiflora Sieb. et Zucc.) Bark in Spontaneously Hypertensive Rats.

Authors:  Kwan Joong Kim; Eun-Sang Hwang; Min-Jeong Kim; Ji-Ho Park; Dae-Ok Kim
Journal:  Antioxidants (Basel)       Date:  2020-04-19

Review 8.  Current Knowledge about the New Drug Firibastat in Arterial Hypertension.

Authors:  Emma Hansen; Daniela Grimm; Markus Wehland
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

9.  S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.

Authors:  Adel S El-Azab; Alaa A-M Abdel-Aziz; Silvia Bua; Alessio Nocentini; Nawaf A AlSaif; Mohammed M Alanazi; Manal A El-Gendy; Hany E A Ahmed; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.